Monday, January 8, 2018

Sanofi to market new hemophilia drug in deal with Alnylam

PARIS, Jan 8 (Reuters) - French pharmaceutical group Sanofi said it has obtained the right to develop and sell a new hemophilia drug in a restructuring of its partnership with U.S. Alnylam Pharmaceuticals.

by support@endlesssupplies.biz (Endless Supplies .Biz) via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)